ORPHAN REACH
Orphan Reach is a global and full-service CRO that has built a reputation for outstanding clinical research addressing rare diseases. We offer global clinical development services that allow our clients to take their precious IMP from early trials in patients to Marketing Authorization. From Project Management to Clinical Monitoring, Safety & Pharmacovigilance, Quality Assurance, Data Management, and Biostatistics: we provide a seamless CRO service. What makes us stand out is the refinement of our processes and adaptation of services to accommodate clinical trials involving small patient numbers. Dealing efficiently with the unique medical, scientific, clinical, and commercial challenges within the rare disease domain, is what our clients appreciate.
ORPHAN REACH
Industry:
Biotechnology Clinical Trials
Founded:
2000-01-01
Address:
Milton Keynes, Milton Keynes, United Kingdom
Country:
United Kingdom
Website Url:
http://www.orphan-reach.com
Total Employee:
101+
Status:
Active
Contact:
+44 (0)1908 251 480
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Sapient
Sapient is a full-service bioanalytical research organization.
Current Employees Featured
Founder
More informations about "Orphan Reach"
Emmes' Rare Disease and Pediatric Center | LinkedIn
Orphan Reach was a leading Contract Research Organization (CRO) designed to navigate the complexity of trials in orphan indications. As of the 11th May 2021, Orphan Reach were acquired by Emmes, a ...See details»
Orphan Reach - Crunchbase Company Profile & Funding
May 13, 2021 Orphan Reach is a global and full-service CRO that has built a reputation for outstanding clinical research addressing rare diseases. We offer global clinical development services that allow our clients to take their …See details»
Emmes launches Orphan Reach™: Emmes’ Rare Disease Center
Nov 3, 2021 Emmes – a full service, global clinical research organization (CRO) – is launching its new center, Orphan Reach™ as a unique ‘rare CRO’. The new rare disease center will …See details»
orphan reach™ - CEO
The Old School Newport Road Woughton Park Milton Keynes MK6 3AP United Kingdom Phone: +44 (0)1908 251 480 Fax: +44 (0)1908 251 499 E-mail: [email protected] Global office locationsSee details»
Orphan Reach services
Emmes launches Orphan Reach™: Emmes’ Rare Disease Center November 3, 2021 Emmes is excited to be attending the World Orphan Drug Congress in the USA August 20, 2021 Orphan Reach confirms acquisition by Emmes, a US …See details»
Orphan Reach - CRO Database - ICH GCP
Orphan Reach is different: We are a boutique service provider solely focused on orphan product candidates supported by a competent team of experts in the field of rare diseases. Our name …See details»
Emmes Acquires UK-Based Orphan Reach - PR Newswire
May 12, 2021 Orphan Reach Founder and CEO Thomas Ogorka said, "Orphan Reach and Emmes share a passion for the research we do, a dedication to the patients in our trials, and …See details»
Emmes Acquires UK-Based Orphan Reach – BioHealth …
ROCKVILLE, Md., May 12, 2021 /PRNewswire/ — Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a …See details»
Orphan Reach 2025 Company Profile: Valuation, …
Orphan Reach General Information Description. Operator of a research organization intended to offer global, dedicated and patient centric orphan drugs. The company offers bespoke services for orphan drug developers that mould …See details»
Emmes' Rare Disease and Pediatric Center | LinkedIn
Orphan Reach was a leading Contract Research Organization (CRO) designed to navigate the complexity of trials in orphan indications. As of the 11th May 2021, Orphan Reach were …See details»
Behrman Capital’s Emmes Completes Acquisition of Orphan Reach
May 14, 2021 The London Private Equity and Life Sciences practices led a cross-border multidisciplinary team in advising Behrman Capital on the completion of its bolt-on acquisition …See details»
orphan reach™ - A global rare disease CRO
Nov 16, 2018 Orphan Reach is a global clinical research organization and has a well established global presence in the majority of countries across each of the major continents. Our highly …See details»
Emmes launches Orphan Reach™: Emmes’ Rare Disease Center
Nov 3, 2021 The expanded Orphan Reach forms a global specialty center dedicated to the advancement of rare disease research by providing specialized clinical trial design and …See details»
HOW IT WORKS – orphan reach™- A Rare Disease CRO for Orphan …
Orphan reach | A rare disease CRO focussing on orphan drugs development HOW IT WORKS – orphan reach™- A Rare Disease CRO for Orphan Drugs Visit the post for more.See details»
Emmes launches Orphan Reach™: Emmes’ Rare Disease Center
Organization (CRO) – is launching its new center, Orphan Reach™ as a unique ‘rare CRO’. The new rare disease center will incorporate Emmes’ world class reputation in public health …See details»
ORPHAN REACH on LinkedIn: So true
Driven by a profound sense of purpose, Kaye founded Orphan Reach, an organization dedicated to rescuing and supporting homeless orphans. His vision extends beyond mere charity; he …See details»
Scientists Map Where Orphan Wells Pose Threats to Aquifers
2 days ago Using a USGS dataset of 117,672 documented orphan wells nationwide, the researchers found that 54 percent of the wells are within aquifers that supply 94 percent of …See details»
Wet-nursing as a new strategy for orphan care in Saudi Arabia
Apr 28, 2025 Saudi Arabia hosts more than 150 charitable institutions dedicated to vulnerable groups, such as orphan care associations that provide orphaned children with food, clothing, …See details»
Emmes launches Orphan Reach™: Emmes’ Rare Disease Center
The New Global Rare Disease Center of Emmes Expects Accelerating Growth from US and European Biotechs. 03 rd November, 2021, Rockville, Maryland (USA): Emmes – a full …See details»
WE HAVE A LOT IN COMMON WITH OUR CLIENTS - orphan …
Latest News. Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research November 16, 2021; Emmes launches Orphan Reach™: …See details»